Topics
High-grade gliomas | Treatment | Clinical trials | TG02
Home > Publications > Topics > High-grade gliomas > Treatment > Clinical trials > TG02
Guo CC, Yang QY, Xi SY, Zhou J, Zhou ZH, Cao X, Liao YX, Li BX,
Dai XR, Wong M, Li YJ, Yu XH, Chen ZP.
Phase
I clinical study of a multi-kinase inhibitor
TG02 capsule for the treatment of
recurrent high-grade gliomas with failed
temozolomide treatment in Chinese
patients.
Chemotherapy.
2024 Nov 18:1-24. doi:
10.1159/000542365. PMID:
39557019. Interventional study˰
ˍ